成人哮喘针刺治疗的临床证据:随机假针刺/安慰剂对照试验的系统评价与Meta分析
结果显示针刺耐受性良好,可改善FEV1%、AQLQ评分、哮喘症状评分、ACT评分并减少急性发作频率,但其他肺功能及用药参数无统计学意义。结论认为针刺可能改善生活质量、FEV1%、症状及哮喘控制,仍需高质量证据进一步验证。
要点
- 针刺耐受性良好,可改善成人哮喘患者FEV1%。
- 针刺可改善AQLQ评分、症状评分、ACT评分并减少急性发作频率。
- 其他肺功能及用药参数无统计学意义,证据质量有限。
核心结论
- 与假针刺/安慰剂对照相比,针刺似乎可改善生活质量、FEV1%、症状及哮喘控制,并减少每年急性发作频率。
研究设计与样本
- 系统评价与Meta分析,检索5个英文数据库和4个中文数据库,从建库至2021年11月。
主要发现
- 针刺改善FEV1%:MD 6.11,95% CI 0.54-11.68,I2=93%,n=603。
- 针刺改善Cai氏哮喘生活质量问卷(AQLQ):MD 7.26,95% CI 5.02-9.50,I2=0,n=358。
- 针刺降低哮喘症状评分:SMD -2.73,95% CI -3.59至-1.87,I2=65%,n=120。
- 一项研究显示针刺提高哮喘控制测试(ACT)评分:MD 2.00,95% CI 0.90-3.10,n=111,并减少急性发作频率:MD -1.00,95% CI -1.55至-1.45,n=111。
- 其他肺功能及用药参数无统计学意义。
临床怎么用
- 成人哮喘患者可考虑针刺作为辅助治疗,以改善FEV1%、生活质量和症状控制。
- 针刺可能减少急性发作频率,但需结合患者具体情况和高质量证据决策。
局限性
- 部分结局异质性较高(如FEV1%的I2=93%)。
- 多数结局样本量较小,证据质量有限。
- 需要更多参与者、适当对照和高证据质量的研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acupuncture is a widely used asthma therapy, but the benefits remain uncertain. This study aimed to access the effectiveness of acupuncture for treatment of asthma in adults. METHODS: Five English databases and four Chinese databases were searched from inception to November 2021. Randomised sham/placebo-controlled trials meeting inclusion criteria were included. Risk of bias was evaluated according to the Cochrane Review Handbook, and data analysis was performed in RevMan 5.4.1. Quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluations (GRADE) profiler. RESULTS: Sixteen randomised controlled trials (RCTs) were included in the meta-analysis. Results indicated that acupuncture was well-tolerated and could improve FEV1% compared with sham/placebo acupuncture [MD 6.11, 95% CI 0.54-11.68, I2 = 93%, number of participants (n) = 603]. Acupuncture also improved Cai's Asthma Quality of Life Questionnaire (AQLQ) (MD 7.26, 95% CI 5.02-9.50, I2 = 0, n = 358), and reduced the asthma symptom score (SMD -2.73, 95% CI -3.59 to -1.87, I2 = 65%, n = 120). One study showed acupuncture increased the Asthma Control Test (ACT) score (MD 2.00, 95% CI 0.90-3.10, n = 111), and decreased exacerbation frequency (MD -1.00, 95% CI -1.55 to -1.45, n = 111). Other lung function and medication use parameters were not statistically significant. CONCLUSIONS: Acupuncture versus sham/placebo control appeared to improve quality of life, FEV1%, symptoms, and asthma control, and reduced exacerbation frequency per year. Further studies with appropriate controls, more participants, and high-quality evidence are needed.
引用
- Pang J, Shergis JL, Zheng L, et al. Clinical evidence for acupuncture for adult asthma: Systematic review and meta-analysis of randomised sham/placebo-controlled trials. Complement Ther Med. 2023. PMID: 37257728. doi:10.1016/j.ctim.2023.102956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。